| 09/10/2026 6:18 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/27/2026 6:07 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 3:04 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/24/2026 3:11 PM | Core Scientific (1839341) Issuer CRAIN ELIZABETH (1604659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 3:13 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2026 3:05 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 11:13 AM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2026 6:02 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2026 3:37 PM | Core Scientific (1839341) Subject JANE STREET GROUP, LLC (1595888) Filed by | Form SCHEDULE 13G/A | |
| 08/12/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 3:40 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
Get the Latest News and Ratings for CORZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Core Scientific and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/04/2026 4:37 PM | Core Scientific (1839341) Subject Situational Awareness LP (2045724) Filed by | Form SCHEDULE 13D/A | |
| 07/31/2026 9:18 AM | Core Scientific (1839341) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 07/22/2026 3:10 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 3:16 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 3:16 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2026 4:41 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 3:45 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2026 6:17 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 6:18 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:14 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:19 PM | Core Scientific (1839341) Subject JANE STREET GROUP, LLC (1595888) Filed by | Form SCHEDULE 13G | |
| 05/26/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 6:46 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 3:49 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:29 AM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 05/13/2026 3:06 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:03 PM | Core Scientific (1839341) Issuer Ray Jorge L. (2123780) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/06/2026 3:54 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/06/2026 3:15 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 6:52 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 11:56 AM | Core Scientific (1839341) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/27/2026 4:30 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 7:59 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/22/2026 3:01 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
What Is A Roth Conversion, And How Do I Set One Up? (Ad) A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax that year in exchange for potential tax-free qualified growth later.
Key questions remain: how much to convert, where the tax payment comes from, and whether this years income leaves room. Roth IRAs also avoid lifetime required minimum distributions.
A fiduciary financial advisor can help size a conversion around your specific tax situation and goals. Get matched with a vetted fiduciary advisor in your area today |
| 04/21/2026 6:36 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/15/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:25 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:26 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 3:44 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/31/2026 3:59 PM | Core Scientific (1839341) Filer | Form DEFA14A | |
| 03/31/2026 4:01 PM | Core Scientific (1839341) Filer | Form ARS | |
| 03/31/2026 3:55 PM | Core Scientific (1839341) Filer | Form DEF 14A | |
| 03/27/2026 5:45 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4/A | |
| 03/26/2026 4:39 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 7:29 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/20/2026 7:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/19/2026 3:06 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 4:14 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 03/12/2026 11:55 AM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 03/10/2026 3:08 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:13 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 8:05 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/02/2026 3:44 PM | Core Scientific (1839341) Filer | Form 10-Q/A | |
| 03/02/2026 3:18 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 02/19/2026 8:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 02/19/2026 10:56 AM | Core Scientific (1839341) Filer | Form 8-K/A | |
| 02/18/2026 4:16 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 10:11 AM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 5:08 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer CRAIN ELIZABETH (1604659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Levy Jordan (1541436) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Booth Jeffrey David (2009493) Reporting Core Scientific (1839341) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:15 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 8:07 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 01/07/2026 1:59 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 01/02/2026 5:26 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 7:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 12/10/2025 5:12 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 12/01/2025 7:04 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/17/2025 5:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/13/2025 4:42 PM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2025 3:05 PM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 10/31/2025 4:16 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/31/2025 3:27 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 3:18 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 9:55 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Why major institutions are piling into this digital asset now (Ad) BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. Get the name, the ticker, and exactly how to buy it |
| 10/30/2025 9:28 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/28/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/24/2025 3:14 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/24/2025 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 4:20 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/21/2025 4:22 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/17/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |